Arnon P. Kater, Yanwen Jiang, Brenda Chyla, John F. Seymour. Response in patients with BIRC3-mutated relapsed/refractory chronic lymphocytic leukemia treated with fixed-duration venetoclax and rituximab. haematol [Internet]. 2020Jul.1 [cited 2024Nov.24];105(7):e382-e383. Available from: https://haematologica.org/article/view/9966